LPAR5 and brain injury: In particular, LPA5 has been suggested to play a pathogenic role in brain ischemic stroke because it can be upregulated in the ischemic core regions after ischemic challenge [9] and suppressing its activity with TCLPA5, a selective LPA5 antagonist, can lead to neuroprotection against ischemic brain injuries during both acute and chronic phases [9,10].